Canadian Institutes of Health Research
Français Contact UsHelpSearchCanada Site
CIHR HomeAbout CIHRWhat's NewFunding OpportunitiesFunding Decisions
CIHR | IRSC
About CIHR
CIHR Institutes
Funding Health Research
Funding News and Developments
Funding Opportunities
Current Funding Opportunities
Description of Program Categories
Archived Funding Opportunities
External Funding Opportunities
How to Apply for Funding
CIHR Funding Policy
Peer Review
Funding Decisions
Funding Related Databases
Training Opportunities
ResearchNet
Knowledge Translation and Commercialization
Partnerships
Major Strategic Initiatives
International Cooperation
Ethics
News and Media
Publications
 

Graduate Training Award - Doctoral Priority Announcement: Genetics (Ethics, Law and Society) (Archived)

CIHR Institute of Genetics (IG)

Request for Applications


Priority Announcements fund highly rated research applications that are determined to be relevant to specific CIHR research priority areas and do not receive funding through CIHR's regular competitions.

Important Dates
Opportunity Launched June 2006
Content Last Updated (No updates since launch)
October 15, 2006 Full applications must be courier stamped by this date.
April 30, 2007 Notification of decision.
April 1, 2007 Earliest start date.
Additional Information Applications are submitted through the October 2006 - Doctoral Research Awards competition
Funds Available

CIHR's contribution to the amount available for this initiative is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them.

The maximum amount awarded for a single award is $ 27,000 for up to three years:

  • Trainee stipend: $ 21,000 per annum.
  • Research allowance: $ 1,000 per annum.
  • For awards held outside Canada, $5,000 is added to the annual stipend.
  • This award is non-renewable.
  • Applications that receive a ranking below 3.7 will not be funded.
Summary

The Institute of Genetics wishes to fund applications that address ethical, legal and social issues relevant to the design, conduct and dissemination of genomic and genetic research; development and application of technologies, and their integration into society. Suggested research areas:

  • Defining "populations" in genomics and genetics research
  • Genetics, populations and public health
  • Access to clinical applications (e.g., patenting, access to clinical trials, "right" to health care)
  • Concepts of risk, communication, appreciation and evaluation
  • Public understanding of science
  • Defining "normalcy," "health," and "disease" in the genomics era
  • Rights and responsibilities in relation to genomics and genetics

Table of Contents

Partners
Objectives
Eligibility
Review Process and Evaluation Criteria
General CIHR Guidelines
Conditions of Funding
How to Apply
Contact Information
Description of Partners

Return to top

Partners

The Institute of Genetics is dedicated to identifying and developing collaborations with other CIHR institute(s), branch(es) or office(s), funding organizations and stakeholders to enhance the availability of funding in their strategic research priority areas and to create, where appropriate, opportunities for knowledge exchange and translation related to the scope of these priority areas. Applicants are invited to visit the Descriptions of Partners to find a list of partners and their respective mandates and/or strategic interests. This list will continue to evolve as new partners join. The specific research foci and requirements for each partner are outlined in the section "Relevant Research Areas".

Return to top

Objectives

The Institute of Genetics wishes to fund applications that address ethical, legal and social issues relevant to the design, conduct and dissemination of genomic and genetic research; development and application of technologies, and their integration into society.

Relevant Research Areas

The Institute of Genetics will fund applications that are determined to be relevant to the research priority areas described below.

Relevance of the applications to the research priorities will be determined in the following manner.

Prior to peer review, representatives from the Institute of Genetics and partner organizations will review applications to determine the relevance, or alignment, of the research proposed to the research priority areas and/or mandates described above.

To conduct relevance review, these representatives will have access to the completed relevance form (see "How to Apply"), anonymized project titles and summaries, provided that applicants have indicated their consent on the "Applicant Consent Form for Use and Disclosure of Personal Information Provided to CIHR for Peer Review," which is included in the application forms.

The following criteria will be used in conducting the relevance review:

Upon completion of peer review, the Institute of Genetics and its partners will receive the ratings, rankings and peer review committee recommendations on funding level and grant or award term for those applications that 1) are found to be relevant to the specific objectives of the research initiative and the research priority areas described under "Relevant Research Areas"; and 2) are rated within the CIHR fundable range but are not funded through the regular CIHR competition to which they were submitted. These applications will be funded from the top down in order of ranking as far as budgets will allow. Applications that receive a ranking below 3.7 will not be funded.

The relevance review occurs apart from the peer review (scientific review) and has no relationship to the results of peer review. Peer review committees will not be informed of applications submitted for funding through this announcement.

Return to top

Eligibility

Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions.

Specific to CIHR training awards, please refer to the General Guidelines for Training Programs as well as the Doctoral Research Awards program description.

Randomized Controlled Trials (RCTs) will not be considered for funding through this Priority Announcement.

Return to top

Review Process and Evaluation Criteria

A CIHR peer review committee will evaluate the full applications. The peer review committee members are selected based on suggestions from many sources including the Institute(s) / portfolio(s) and partner(s), following CIHR's Policy on Confidentiality, Conflict of Interest and Privacy Issues in Peer and Relevance Review (CCIP). For information on CIHR's peer review process in general, see Peer Review.

Return to top

General CIHR Guidelines

This Priority Announcement will follow the CIHR General Grants and Awards Policies. Applicants are encouraged to demonstrate the use of gender and sex-based analysis in applications.

Return to top

Conditions of Funding

All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through this Priority Announcement. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official language policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR Support. Successful applicants will be informed of any special financial conditions prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document.

Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)

All personal information collected by CIHR about applicants is used to review applications, to recruit reviewers, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review.

CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR's premises including, without limitation, cost-sharing agreements related to this priority announcement and all matters pertaining thereto.

While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the priority announcement will be collected, used and disclosed in compliance with the PIPEDA.

Return to top

How to Apply

Applicants are advised to review CIHR's grants and awards policies and guidelines outlined in the CIHR Grants and Awards Guide.

Applications are submitted through the October 2006 Doctoral Research Awards competition by including a mandatory Relevance Form with your regular Doctoral Research Award application. To select the appropriate application forms, follow the links beside "Doctoral Research Award - Application" from the list of Application Packages)

Additional Instructions for this Priority Announcement:

Return to top

Contact Information

For questions about the objectives and relevant research areas:

Jennifer Jennings
Project Manager, CIHR Institute of Genetics
123 Edward Street, Suite 1211
Toronto ON M5G 1E2
Telephone: (416) 813-7400
Fax: (416) 813-7673
Email: jennig@sickkids.ca

For questions related to specific CIHR competitions and programs, including CIHR funding guidelines, how to apply, and the peer review process contact:

Leah Jurkovic
Program Delivery Coordinator
Canadian Institutes of Health Research
Telephone: (613) 946-0088
Fax: (613) 954-1800
Email: ljurkovic@cihr-irsc.gc.ca

Return to top

Description of Partners: CIHR Institutes and Partner Organizations

Canadian Institutes of Health Research (CIHR)
CIHR is Canada's major federal funding agency for health research. Its objective is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system.

CIHR - Institute of Genetics (IG)
Supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries.

Partners

Note: Additional partners, including partners from industry and the private sector are expected.


Created: 2006-06-15
Modified: 2006-06-15
Reviewed: 2006-06-15
Print